For what concerns the role of PD-1/PD-L1 in COVID-19, it should be noted that one of the first clinical and laboratory observations in patients infected by COVID-19 was the finding of lymphopenia, and the correlation of worsening lymphopenia with disease progression and disease severity [65,134]. Here, CD274 is linked to COVID-19.